Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 801–850 of 4,603 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07313852	A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia	not yet recruiting	Phase 1 / Phase 2	26	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 11, 2026	clinicaltrials
NCT07432984	Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC(FMT-LUNG)	not yet recruiting	Phase 2	15	Se-Hoon LeeOTHER	0	Aug 11, 2026